Connective Tissue + Tendon Disease Flashcards

1
Q

Connective tissue diseases

  • What are they not?
  • Characterized by?
  • Associated with?
A

NOT diseases of connective tissue
Characterized by the presence of spontaneous over-activity of the immune system
Often associated with specific auto-antibodies which can help define the diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Systemic lupus erythethmatosus
What is it?
What causes it?

A

This is a multisystemic autoimmune disease that can affect any part of the body.
The immune system attacks the body’s cells and tissue, resulting in inflammation and tissue damage.
Antibody-immune complexes precipitate and cause a further immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SLE epidemiology

  • Male:female ratio?
  • Typical patient?
  • Where in world is prevalence higher?
A

Females more than males 9:1
Typical patient is woman of childbearing age
Prevalence is higher (and disease is typically more severe in) in Asians, Afro-Americans, Afro-Caribbean’s and Hispanic Americans compared with Americans of European descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aetiology of SLE?

A

This is an interplay between several different things – someone has to be genetically predisposed to it, and other things trigger it, e.g. hormonal factors (like being on the pill).
Genetic factors: high concordance in monozygotic twins, increased incidence amongst relatives, identification of gene abnormalities predisposing to lupus.
Hormonal factors: incidence increased in those with higher oestrogen exposure - early menarche, on oestrogen containing contraceptives and HRT.
Environmental factors
- Viruses e.g. Epstein-Barr Virus
- UV light may stimulate skin cells to secrete cytokines stimulating B-cells
- Silica dust (found in cleaning powders, cigarette smoke and cement) may increase risk of developing SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Function of T cells?

A

T cells do a couple of things – 1. They stimulate B cells to produce antibodies against the antigen; 2. They stimulate toxic T cells to destroy cells that express the antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of SLE?

A

In a healthy human, when cells break down they are cleared very quickly. In lupus, that process stops working effectively and that means that the cell contents float about in the system for much longer than they would do otherwise. If there is prolonged exposure to the contents of the cell nucleus, the immune system starts to see them as being alien to the body and starts producing antibodies against them.
I.e. there is increased and defective apoptosis (programmed cell death) -> necrotic cells release nuclear material which act as potential auto-antigens -> autoimmunity probably results from the extended exposure to nuclear and intracellular auto-antigens -> B and T cells are stimulated -> autoantibodies are produced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiology of renal SLE?

A
  • Likely due to deposition of immune complexes in mesangium
  • Complexes consist of nuclear antigens and anti-nuclear antibodies
  • Complexes form in circulation then are deposited
  • Once present they activate complement which attracts leucocytes which release cytokines
  • Cytokine release perpetuates inflammation which, over time, causes necrosis and scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do complement levels in the blood relate to SLE disease activity?

A

Immune complex deposition lowers complement levels -> measure this in the blood and if it is low, then disease activity is likely to be high.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnostic criteria for SLE?

A

Four criteris with at least one criteria + one immunologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which systems does SLE affect?

A
Mucocutaneous
Musculoskeletal
(Serositis)
Renal
Neurological
Haematological
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Constitutional symptoms of SLE?

A
Fever
Malaise
Poor appetite
Weight loss
Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Mucocutaneous symptoms of SLE?
Fever
Malaise
Poor appetite
Weight loss
Fatigue
A
Photosensitivity
Malar rash - may or may not be associated with sun exposure – tends to come out after being in the sun and then lasts for quite a while; spares the naso-lablial folds
Discoid lupus erythematosus (may scar)
Subacute cutaneous lupus
Mouth ulcers (painless)
Alopecia (non-scarring)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Musculoskeletal features of SLE?

A

Non-deforming polyarthritis/polyarthralgia RA distribution but no radiological erosion
Deforming arthropathy - Jaccoud’s arthritis
Erosive arthritis - rare
Myopathy - weakness, myalgia & myositis
Despite hands looking very deformed, x-rays typically look very normal.
SLE patients are able to form a fist; rheumatoid patients are not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SLE cause serositis.
What is this?
What does it cause?

A
Serositis – basically just inflammation of the lining of something
Pericarditis
Pleurisy
Pleural effusion
Pericardial effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the symptoms of renal SLE?

A

Renal features – typically don’t cause symptoms

  • Proteinuria of >500mg in 24 hours
  • Red cell casts
  • Only get microscopic visible haematuria
  • You need to actively screen for renal disease, otherwise you won’t know it’s there
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neurological features of SLE?

A

These are less common than other features
Depression/psychosis
Not always related to disease activity – difficult to tell
Migrainous headache
Seizures
Cranial or peripheral Neuropathy
Mononeuritis multiplex – caused by destruction of the blood vessels which supply nerves i.e. vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Haematological features of SLE

A
Lymphadenopathy - ~25% of all patients during their course of illness
Leucopenia
Lymphopenia
Haemolytic anaemia
Thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antiphospholipid syndrome
Which condition is this associated with?
What antibodies are involved?
Pnemonic for remembering symptoms?

A

Can be associated with SLE (20-30%) Anticardiolipin & lupus anticoagulant
Causes CLOTS:
Coagulation defect
Livedo reticularis - strange skin colour pattern, typically on the thighs, as shown opposite
Obstetric – recurrent miscarriage
Thrombocytopaenia - ↓platelets
This condition causes venous and arterial thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do caucasians tend to present?

A

Caucasian patients tend to be at the mild end of the spectrum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the two aims of lupus investigation?

A

To confirm/establish diagnosis

To determine degree of organ involvement

21
Q

Anti-nuclear antibody (ANA)
Positive titre in what % of SLE patients?
What other conditions is it associated with?

A

Positive titre in 95%

Found in conditions such as rheumatoid arthritis, other autoimmune conditions, HIV, hepatitis C

22
Q

When should a positive test for ANA be taken seriously?

A
  1. If other anti-nuclear antibodies are positive, e.g. anti-dsDNA, anti-Sm, anti-Ro, anti-RNP (these indicate some form of connective tissue disease, but not specific to lupus)
  2. When the patient presents with connective tissue disease features
23
Q

Anti-double stranded antibody (anti-dsDNA)
What % of SLE patients have a positive titre?
Specific or non-specific?
What does titre correlate with?
What might it be associated with?

A

Occurs in ~60% of patients with SLE
Highly specific for SLE
Titre correlates with overall disease activity – this is a very useful quality of testing for this antibody
May be associated with lupus nephritis

24
Q

What is the risk if a mother is anti-Ro positive?

A

If a mother is anti-Ro positive, her baby is at much higher risk of both lupus and heart block.

25
Q

Anti-SM
Specificity?
Associated with?

A

Anti-Sm is highly specific (10 - 20%)  probable association with neurological involvement.

26
Q

What investigation must you do in a patient with SLE?

A

Urinalysis to screen for kidney disease

27
Q

Monitoring SLE activity
How is this done?
Which antigen correlates with disease activity?
How do C3/4 levels vary with disease activity?

A

Thorough clinical assessment including BP
Anti-dsDNA level positively correlates with activity
C3/C4 levels negatively correlate with activity i.e. low complement means active disease
Urine examination including protein, cells and casts

28
Q

What should a fall in C4 make you think of?

A

SLE disease flare

29
Q

What drug management is used for SLE?

A

NSAIDs and simple analgesia
Anti malarials - hydroxychloroquine
Steroids can be used but with caution and avoidance if possible
Immunosuppressants e.g. azathioprine, cyclophosphamide, methotrexate
Biologic agents

30
Q

Describe the different categories of SLE severity and the treatment for each.

A
Severe flares (acute SLE i.e. haemolytic anaemia, nephritis, severe pericarditis or CNS disease) – requires urgent cyclophosphamide + high dose prednisolone
Cutaneous symptoms – treat rashes with topical steroids; prevent rashes with high factor sun block 
Maintenance – use NSAIDs and hydroxychloroquine for joint and skin symptoms; low dose steroids may be of some use in chronic disease; azathioprine, methotrexate and mycophenolate are used as steroid-sparing agents
31
Q

Anti-phospholipid syndrome clinical features?

A

Remember clinical features as CLOTS:
Coagulation defect
Livedo reticularis - strange skin colour pattern, typically on the thighs, as shown opposite
Obstetric – recurrent miscarriage
Thrombocytopaenia - ↓platelets
Arterial / venous thrombosis is another defining feature.

32
Q

What should you think of in pregnancy loss of with no other explanation 10-34/40 or 3 pregnancy losses with no other explanation <10/40 or 1 pre-term <34/40 because of eclampsia, severe pre-eclampsia or with signs of placental insufficiency?

A

Anti-phospholipid syndrome

33
Q

Epidemiology of anti-phospholipid syndrome?
Who gets it?
Male:female ratio?
Assocaited with which antibody?

A

Responsible for 15% of cases of recurrent foetal loss and 20% of recurrent thrombosis in young people
Occurs in young women M:F 1:3.5
~30% people with SLE have anti-cardiolipin antibodies (may occur in other CTDs)
1-5% healthy population have anti-cardiolipin antibodies

34
Q

Treatment of anti-phospholipid syndrome?

A

Thrombosis – lifelong anti-coagulation
Pregnancy loss – aspirin + heparin during pregnancy
Attention to vascular risk factors – all of these conditions are cardiovascular risk factors

35
Q

Sjogren’s syndrome

What is this?

A

This is a chronic inflammatory autoimmune disorder or secondary (to other autoimmune conditions). It is characterized by lymphocyte infiltration and fibrosis of exocrine glands causing xerostomia (dry mouth) and keratoconjunctivitis sicca (dryness of the conjunctiva).
Other exocrine glands can be involved, causing vaginal dryness, dyspareunia, dry cough and dysphagia.

36
Q

Which autoantibodies are associated with Sjogrens?

A

Anti-Ro

Anti-la

37
Q

What are some other manifestations of Sjogren’s syndrome?

A
Fatigue 
Arthralgia
Raynauds
Salivary swelling
Lymphadenopathy
Skin and vaginal dryness
Interstitial lung disease
Neuropathy
Lymphoma (x40 risk)
Renal tubular acidosis
Neonatal complete heart block (anti-Ro)
38
Q

Treatment of Sjogren’s syndrome?

A
Eye drops, punctal plugs
Saliva replacement
Pilocarpine
Hydroxychloroquine
Steroids and immunosuppression 
Attention to cardiovascular risk factors
39
Q

Systemic sclerosis

What three things characterize this?

A

Vasculopathy (Raynaud’s Syndrome)
Inflammation
Fibrosis – excess deposition of collagen in skin and internal organs

40
Q

What are the two types of scleroderma you need to focus on?

What is the difference between the two?

A

Diffuse systemic sclerosis and limited systemic sclerosis

In limited, involvement is “limited” to the face, hands and feet

41
Q

Limited systemic sclerosis
What does it cause?
Which antibody is it associated with?

A
Remember this as PH CREST:
Pulmonary Hypertension
Calcinosis
Raynauds
Esophageal dysmotility
Sclerodactyly
Telangectasia
Anti-centromere antibodies
42
Q

Diffuse systemic sclerosis

  • What other skin is involved?
  • Organ involvement?
  • Which antibodies?
A

Truncal and acral skin involvement
Early significant organ involvement (kidneys, lungs, gut, muscle, joints, heart)
Anti-Scl-70 antibodies

43
Q

What are some cutaneous features of systemic sclerosis?

A

Skin tightening
Facial and oral telangectasia
Leathery skin on hands

44
Q

Describe the organ manifestations of diffuse systemic sclerosis

A
GI
- Oesophageal hypomobility
- Small bowel hypomobility, bacterial overgrowth
- Pancreatic insufficiency
- Rectal hypomobility
Respiratory 
- Interstitial lung disease
- Pulmonary hypertension
- Chest wall restriction 
Renal
- Hypertensive renal crisis
- Ischaemic
Cardiovascular 
- Raynaud’s with digital ulceration
- Atherosclerotic disease
- Hypertensive cardiomyopathy
45
Q

Epidemiology of diffuse and limited systemic sclerosis
Peak age?
Prevalence?
Male:female ratio?

A

Peak age 25-55
Prevalence 1:10,000
M:F 1:4

46
Q

Treatment of diffuse and limited systemic sclerosis

A
Calcium channel blockers
Prostacyclin (Iloprost)
ACE inhibitors
Prednisolone
Immunosuppression
Bosentan, Sildenafil
47
Q

Mixed connective tissue disease

Combines features of which diseases?

A

This combines features of systemic sclerosis, SLE and polymyositis.

48
Q
Give the autoantibody (s) for the following conditions
SLE
Sjogren’s syndrome
Systemic sclerosis
Mixed connective tissue disease
Polymyositis
Anti-phospholipid syndrome
A

SLE - ANA, Anti-DNA binding, Anti-Sm, Anti-Ro and La
Sjogren’s syndrome - Anti-Ro and La
Systemic sclerosisAnti- centromere, Anti-scl-70
Mixed connective tissue disease - Anti-RNP
Polymypsitis - Anti-Jo-1
Anti-phospholipid syndrome - Anti-cardiolipin antibodies, lupus anti coagulant